Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

Implementing an integrated pathway to care for the dying: is your organisation ready?

Sharpe KK, Noble C, Hiremagular B, Grealish L.

Int J Palliat Nurs. 2018 Feb 2;24(2):70-78. doi: 10.12968/ijpn.2018.24.2.70.

PMID:
29469642
2.

Core Temperature Responses to Cold-Water Immersion Recovery: A Pooled-Data Analysis.

Stephens JM, Sharpe K, Gore C, Miller J, Slater GJ, Versey N, Peiffer J, Duffield R, Minett GM, Crampton D, Dunne A, Askew CD, Halson SL.

Int J Sports Physiol Perform. 2018 Aug 1;13(7):917-925. doi: 10.1123/ijspp.2017-0661. Epub 2018 Jul 30.

PMID:
29283744
3.

The athlete's hematological response to hypoxia: A meta-analysis on the influence of altitude exposure on key biomarkers of erythropoiesis.

Lobigs LM, Sharpe K, Garvican-Lewis LA, Gore CJ, Peeling P, Dawson B, Schumacher YO.

Am J Hematol. 2018 Jan;93(1):74-83. doi: 10.1002/ajh.24941. Epub 2017 Oct 31.

PMID:
29027252
4.

Inequalities in the dental health needs and access to dental services among looked after children in Scotland: a population data linkage study.

McMahon AD, Elliott L, Macpherson LM, Sharpe KH, Connelly G, Milligan I, Wilson P, Clark D, King A, Wood R, Conway DI.

Arch Dis Child. 2018 Jan;103(1):39-43. doi: 10.1136/archdischild-2016-312389. Epub 2017 Aug 30.

PMID:
28855231
5.

Using Patient-Reported Outcome Measures (PROMs) to promote quality of care and safety in the management of patients with Advanced Chronic Kidney disease (PRO-trACK project): a mixed-methods project protocol.

Aiyegbusi OL, Kyte D, Cockwell P, Marshall T, Dutton M, Slade A, Marklew N, Price G, Verdi R, Waters J, Sharpe K, Calvert M.

BMJ Open. 2017 Jun 30;7(6):e016687. doi: 10.1136/bmjopen-2017-016687.

6.

Linking routinely collected social work, education and health data to enable monitoring of the health and health care of school-aged children in state care ('looked after children') in Scotland: a national demonstration project.

Clark D, King A, Sharpe K, Connelly G, Elliott L, Macpherson LMD, McMahon AD, Milligan I, Wilson P, Conway DI, Wood R.

Public Health. 2017 Sep;150:101-111. doi: 10.1016/j.puhe.2017.05.003. Epub 2017 Jun 27.

PMID:
28666173
7.

Characterization of aminoaciduria and hypoaminoacidemia in dogs with hepatocutaneous syndrome.

Loftus JP, Center SA, Lucy JM, Stanton JA, McDonough SP, Peters-Kennedy J, Arceneaux KA, Bechtold MA, Bennett CL, Bradbury CA, Cline MG, Hall-Fonte DL, Hammer-Landrum JF, Huntingford JL, Marshall J, Sharpe KS, Redin JL, Selva ST, Lucia TA.

Am J Vet Res. 2017 Jun;78(6):735-744. doi: 10.2460/ajvr.78.6.735.

PMID:
28541155
8.

Hereditary leiomyomatosis and renal cell cancer (HLRCC): cutaneous and renal manifestations requiring a multidisciplinary team approach.

Adams A, Sharpe KK, Peters P, Freeman M.

BMJ Case Rep. 2017 Apr 11;2017. pii: bcr-2016-215115. doi: 10.1136/bcr-2016-215115.

PMID:
28400389
9.

Preparedness and Cancer-Related Symptom Management among Cancer Survivors in the First Year Post-Treatment.

Leach CR, Troeschel AN, Wiatrek D, Stanton AL, Diefenbach M, Stein KD, Sharpe K, Portier K.

Ann Behav Med. 2017 Aug;51(4):587-598. doi: 10.1007/s12160-017-9880-6.

PMID:
28224276
10.

Temporal changes in physiology and haematology in response to high- and micro-doses of recombinant human erythropoietin.

Clark B, Woolford SM, Eastwood A, Sharpe K, Barnes PG, Gore CJ.

Drug Test Anal. 2017 Oct;9(10):1561-1571. doi: 10.1002/dta.2176. Epub 2017 Apr 11.

PMID:
28214385
11.

Multidrug-resistant Fusarium keratitis: diagnosis and treatment considerations.

Sara S, Sharpe K, Morris S.

BMJ Case Rep. 2016 Aug 3;2016. pii: bcr2016215401. doi: 10.1136/bcr-2016-215401.

12.

Last Word on Viewpoint: Time for a new metric for hypoxic dose?

Garvican-Lewis LA, Sharpe K, Gore CJ.

J Appl Physiol (1985). 2016 Jul 1;121(1):359. doi: 10.1152/japplphysiol.00457.2016. No abstract available.

13.

New insights for identification of doping with recombinant human erythropoietin micro-doses after high hydration.

Martin L, Ashenden M, Bejder J, Hoffmann M, Nordsborg N, Karstoft K, Morkeberg J, Sharpe K, Lasne F, Marchand A.

Drug Test Anal. 2016 Nov;8(11-12):1119-1130. doi: 10.1002/dta.2004. Epub 2016 Jul 8.

PMID:
27390252
14.

A Dichotomy of Information-Seeking and Information-Trusting: Stem Cell Interventions and Children with Neurodevelopmental Disorders.

Sharpe K, Di Pietro N, Jacob KJ, Illes J.

Stem Cell Rev. 2016 Aug;12(4):438-47. doi: 10.1007/s12015-016-9667-3.

PMID:
27286955
15.

Practical solutions when facing cost sharing: the American Cancer Society's Health Insurance Assistance Service.

Sharpe K, Shaw B, Battaglia Seiler M.

Am J Manag Care. 2016 Mar;22(4 Suppl):s92-4.

16.

Hepatocutaneous syndrome in Shih Tzus: 31 cases (1996-2014).

Hall-Fonte DL, Center SA, McDonough SP, Peters-Kennedy J, Trotter TS, Lucy JM, Berger E, Byers C, Cummings CG, Burke E, Stegemen J, Pintar J, Kantrowitz L, Sharpe K, Weinkle T.

J Am Vet Med Assoc. 2016 Apr 1;248(7):802-13. doi: 10.2460/javma.248.7.802.

PMID:
27003022
17.

Time for a new metric for hypoxic dose?

Garvican-Lewis LA, Sharpe K, Gore CJ.

J Appl Physiol (1985). 2016 Jul 1;121(1):352-5. doi: 10.1152/japplphysiol.00579.2015. Epub 2016 Feb 25. No abstract available.

18.

Hypoxia-induced cardiac injury in dystrophic mice.

Stelter Z, Strakova J, Yellamilli A, Fischer K, Sharpe K, Townsend D.

Am J Physiol Heart Circ Physiol. 2016 Apr 1;310(7):H938-48. doi: 10.1152/ajpheart.00917.2015. Epub 2016 Feb 5.

19.

Ductal Plate Malformation in the Liver of Boxer Dogs: Clinical and Histological Features.

Pillai S, Center SA, McDonough SP, Demarco J, Pintar J, Henderson AK, Cooper J, Bolton T, Sharpe K, Hill S, Benedict AG, Haviland R.

Vet Pathol. 2016 May;53(3):602-13. doi: 10.1177/0300985815610567. Epub 2016 Jan 21.

PMID:
26797094
20.

The American Cancer Society's Approach to Addressing the Cancer Burden in the LGBT Community.

Wender R, Sharpe KB, Westmaas JL, Patel AV.

LGBT Health. 2015 Nov 5. [Epub ahead of print]

PMID:
26789399
21.
22.

The silence of prozac.

Sharpe K.

Lancet Psychiatry. 2015 Oct;2(10):871-3. doi: 10.1016/S2215-0366(15)00430-7. Epub 2015 Sep 29. No abstract available.

PMID:
26462219
23.

In the Know and in the News: How Science and the Media Communicate About Stem Cells, Autism and Cerebral Palsy.

Sharpe K, Di Pietro N, Illes J.

Stem Cell Rev. 2016 Feb;12(1):1-7. doi: 10.1007/s12015-015-9627-3.

PMID:
26454430
24.

American Cancer Society Colorectal Cancer Survivorship Care Guidelines.

El-Shami K, Oeffinger KC, Erb NL, Willis A, Bretsch JK, Pratt-Chapman ML, Cannady RS, Wong SL, Rose J, Barbour AL, Stein KD, Sharpe KB, Brooks DD, Cowens-Alvarado RL.

CA Cancer J Clin. 2015 Nov-Dec;65(6):428-55. doi: 10.3322/caac.21286. Epub 2015 Sep 8. Review.

25.

Reliability and accuracy of six hand-held blood lactate analysers.

Bonaventura JM, Sharpe K, Knight E, Fuller KL, Tanner RK, Gore CJ.

J Sports Sci Med. 2015 Mar 1;14(1):203-14. eCollection 2015 Mar.

26.

Lack of early dislocation following total hip arthroplasty with a new dual mobility acetabular design.

Vigdorchik JM, D'Apuzzo MR, Markel DC, Malkani AL, Raterman S, Sharpe KP, Cornell CN, Westrich GH.

Hip Int. 2015 Jan-Feb;25(1):34-8. doi: 10.5301/hipint.5000186. Epub 2015 Feb 3.

PMID:
25655740
27.

Dystrobrevin increases dystrophin's binding to the dystrophin-glycoprotein complex and provides protection during cardiac stress.

Strakova J, Dean JD, Sharpe KM, Meyers TA, Odom GL, Townsend D.

J Mol Cell Cardiol. 2014 Nov;76:106-15. doi: 10.1016/j.yjmcc.2014.08.013. Epub 2014 Aug 24.

28.

Regarding "reverse total shoulder arthroplasty for acute proximal humeral fracture: comparison to open reduction-internal fixation and hemiarthroplasty".

Arshad MS, Sharpe KR.

J Shoulder Elbow Surg. 2014 Sep;23(9):e221. doi: 10.1016/j.jse.2014.05.018. Epub 2014 Jul 24. No abstract available.

PMID:
25066821
29.

Laparoscopic kidney transplant by extra peritoneal approach: the safe transition from laboratory to the clinic.

He B, Mou L, Sharpe K, Swaminathan R, Hamdorf J, Delriviere L.

Am J Transplant. 2014 Aug;14(8):1931-6.

30.

School daze.

Sharpe K.

Lancet Psychiatry. 2014 Jul;1(2):118. doi: 10.1016/S2215-0366(14)70293-7. Epub 2014 Jul 9. No abstract available.

PMID:
26360572
31.

Psychological outcomes in critically ill patients receiving renal replacement therapy: a matched-pairs analysis.

Paddle JJ, Sharpe KA, Boyd N, Burt K.

Anaesthesia. 2014 Oct;69(10):1127-32. doi: 10.1111/anae.12756. Epub 2014 Jun 9.

32.

Ticking the boxes.

Sharpe K.

Lancet Psychiatry. 2014 Jun;1(1):e1. doi: 10.1016/S2215-0366(14)70231-7. Epub 2014 Jun 4. No abstract available.

PMID:
26360406
33.

Out of time.

Sharpe K.

Lancet Psychiatry. 2014 Jun;1(1):21-2. doi: 10.1016/S2215-0366(14)70270-6. Epub 2014 Jun 4. No abstract available.

PMID:
26360398
34.

Prediction of Crohn's disease aggression through NOD2/CARD15 gene sequencing in an Australian cohort.

Bhullar M, Macrae F, Brown G, Smith M, Sharpe K.

World J Gastroenterol. 2014 May 7;20(17):5008-16. doi: 10.3748/wjg.v20.i17.5008.

35.

Policy for home or hospice as the preferred place of death from cancer: Scottish Health and Ethnicity Linkage Study population cohort shows challenges across all ethnic groups in Scotland.

Sharpe KH, Cezard G, Bansal N, Bhopal RS, Brewster DH.

BMJ Support Palliat Care. 2015 Dec;5(4):443-51. doi: 10.1136/bmjspcare-2013-000485. Epub 2013 Nov 19.

PMID:
24644191
36.

Association between socioeconomic factors and cancer risk: a population cohort study in Scotland (1991-2006).

Sharpe KH, McMahon AD, Raab GM, Brewster DH, Conway DI.

PLoS One. 2014 Feb 27;9(2):e89513. doi: 10.1371/journal.pone.0089513. eCollection 2014.

37.

Medication: the smart-pill oversell.

Sharpe K.

Nature. 2014 Feb 13;506(7487):146-8. doi: 10.1038/506146a. No abstract available.

PMID:
24522583
38.

Stability of athlete blood passport parameters during air freight.

Ashenden M, Sharpe K, Plowman J, Allbon G, Lobigs L, Baron A, Gore CJ.

Int J Lab Hematol. 2014 Oct;36(5):505-13. doi: 10.1111/ijlh.12178. Epub 2013 Dec 27.

PMID:
24373122
39.

A population study of urine glycerol concentrations in elite athletes competing in North America.

Kelly BN, Madsen M, Sharpe K, Nair V, Eichner D.

Drug Test Anal. 2013 Nov-Dec;5(11-12):890-5. doi: 10.1002/dta.1537. Epub 2013 Sep 24.

PMID:
24353191
40.

Altitude training and haemoglobin mass from the optimised carbon monoxide rebreathing method determined by a meta-analysis.

Gore CJ, Sharpe K, Garvican-Lewis LA, Saunders PU, Humberstone CE, Robertson EY, Wachsmuth NB, Clark SA, McLean BD, Friedmann-Bette B, Neya M, Pottgiesser T, Schumacher YO, Schmidt WF.

Br J Sports Med. 2013 Dec;47 Suppl 1:i31-9. doi: 10.1136/bjsports-2013-092840. Review.

41.

The effect of VEGF-targeted therapy on biomarker expression in sequential tissue from patients with metastatic clear cell renal cancer.

Sharpe K, Stewart GD, Mackay A, Van Neste C, Rofe C, Berney D, Kayani I, Bex A, Wan E, O'Mahony FC, O'Donnell M, Chowdhury S, Doshi R, Ho-Yen C, Gerlinger M, Baker D, Smith N, Davies B, Sahdev A, Boleti E, De Meyer T, Van Criekinge W, Beltran L, Lu YJ, Harrison DJ, Reynolds AR, Powles T.

Clin Cancer Res. 2013 Dec 15;19(24):6924-34. doi: 10.1158/1078-0432.CCR-13-1631. Epub 2013 Oct 15.

42.

Alterations of dystrophin-associated glycoproteins in the heart lacking dystrophin or dystrophin and utrophin.

Sharpe KM, Premsukh MD, Townsend D.

J Muscle Res Cell Motil. 2013 Dec;34(5-6):395-405. doi: 10.1007/s10974-013-9362-9. Epub 2013 Oct 6.

43.

Benefits and constraints of intimate partnerships for HIV positive sex workers in Kibera, Kenya.

Benoit C, Roth E, Hallgrimsdottir H, Jansson M, Ngugi E, Sharpe K.

Int J Equity Health. 2013 Sep 3;12:76. doi: 10.1186/1475-9276-12-76.

44.

A prospective evaluation of VEGF-targeted treatment cessation in metastatic clear cell renal cancer.

Powles T, Kayani I, Sharpe K, Lim L, Peters J, Stewart GD, Berney D, Sahdev A, Chowdhury S, Boleti E, Shamash J, Reynolds AR, Jones R, Blank C, Haanen J, Bex A.

Ann Oncol. 2013 Aug;24(8):2098-103. doi: 10.1093/annonc/mdt130. Epub 2013 Apr 11.

PMID:
23579815
45.

Advancing survivorship care through the National Cancer Survivorship Resource Center: developing American Cancer Society guidelines for primary care providers.

Cowens-Alvarado R, Sharpe K, Pratt-Chapman M, Willis A, Gansler T, Ganz PA, Edge SB, McCabe MS, Stein K.

CA Cancer J Clin. 2013 May;63(3):147-50. doi: 10.3322/caac.21183. Epub 2013 Mar 19.

46.

The effects of injury and illness on haemoglobin mass.

Gough CE, Sharpe K, Garvican LA, Anson JM, Saunders PU, Gore CJ.

Int J Sports Med. 2013 Sep;34(9):763-9. doi: 10.1055/s-0033-1333692. Epub 2013 Feb 26.

PMID:
23444086
47.

Documenting the health insurance needs of cancer patients and providing scarce resolutions.

Wiatrek DE, Morra M, Shaw B, Sharpe K, George R, Battaglia-Seiler M, Fellers M.

J Cancer Educ. 2013 Jun;28(2):221-7. doi: 10.1007/s13187-013-0451-7.

PMID:
23371058
48.

Milestones in mission: the work of the American Cancer Society's mission delivery.

Sharpe K, Perocchia RS, Wiatrek DE, Shaw B.

J Cancer Educ. 2013 Mar;28(1):4-8. doi: 10.1007/s13187-012-0448-7.

PMID:
23355277
49.

Detection of microdoses of rhEPO with the MAIIA test.

Mørkeberg J, Sharpe K, Karstoft K, Ashenden MJ.

Scand J Med Sci Sports. 2014 Aug;24(4):634-41. doi: 10.1111/sms.12049. Epub 2013 Jan 24.

PMID:
23347069
50.

Parkin ubiquitinates Tar-DNA binding protein-43 (TDP-43) and promotes its cytosolic accumulation via interaction with histone deacetylase 6 (HDAC6).

Hebron ML, Lonskaya I, Sharpe K, Weerasinghe PP, Algarzae NK, Shekoyan AR, Moussa CE.

J Biol Chem. 2013 Feb 8;288(6):4103-15. doi: 10.1074/jbc.M112.419945. Epub 2012 Dec 20.

Supplemental Content

Loading ...
Support Center